Drug Side Effects
Search
PARVOVIRUS B19 INFECTION REACTIVATION
PARVOVIRUS B19 INFECTION REACTIVATION
was reported 32 times
These drug classes are most commonly taken by patients reporting PARVOVIRUS B19 INFECTION REACTIVATION:
#
Drug
Count
0
Antimetabolite Immunosuppressant [EPC]
11
1
CD20-directed Cytolytic Antibody [EPC]
10
2
Kinase Inhibitor [EPC]
10
3
mTOR Inhibitor Immunosuppressant [EPC]
10
4
Interleukin-2 Receptor Blocking Antibody [EPC]
9
5
Calcineurin Inhibitor Immunosuppressant [EPC]
8
6
Corticosteroid [EPC]
8
7
Human Immunoglobulin G [EPC]
4
8
Alkylating Drug [EPC]
2
9
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
10
Folate Analog Metabolic Inhibitor [EPC]
2
11
Glycopeptide Antibacterial [EPC]
2
12
Janus Kinase Inhibitor [EPC]
2
13
Nitroimidazole Antimicrobial [EPC]
2
14
Anthracycline Topoisomerase Inhibitor [EPC]
1
15
CD52-directed Cytolytic Antibody [EPC]
1
16
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
17
Nucleoside Analog Antiviral [EPC]
1
18
Nucleoside Metabolic Inhibitor [EPC]
1
19
Sulfonamide Antimicrobial [EPC]
1